Share Facebook Twitter LinkedIn Pinterest Email Notable analyst calls this week: J&J, Intel and Adobe among top picks
Roche lung cancer drug extends survival by nearly six months in late-stage trial (RHHBY:OTCMKTS)October 25, 2026